Investigation Report on China Remifentanil Market, 2009-2018
|出版商||China Research and Intelligence||商品編碼||338986|
|出版日期||內容資訊||英文 20 Pages
|RemiFentanyl的中國市場 Investigation Report on China Remifentanil Market, 2009-2018|
|出版日期: 2015年09月07日||內容資訊: 英文 20 Pages||
RemiFentanyl (鹽酸RemiFentanyl) 是新世代的鎮靜劑，由於短時間的作用表現和控制性高而成為理想的靜脈麻醉劑。中國國內的調查對象醫院，RemiFentanyl的銷售額 (2014年)為 2億人民幣，2005∼2014年的年複合成長率(CAGR) 成為30％以上。隨著人口高齡化，及環境污染、生活習慣的變化伴隨的疾病增加，中國國內的手術數量增加，預期RemiFentanyl的需求也將擴大。
As a new generation of opiates, remifentanil (remifentanil hydrochloride) is an ideal intravenous anesthetic with short onset and good controllability. Remifentanil hydrochloride injection is a narcotic used for the maintenance of general anesthesia.
In China, there is still a large space for narcotic market to grow. And fentanyl takes up over 50% i.e. CNY 5 billion of the narcotic market. As remifentanil is addictive, its production and sales is strictly controlled by the Chinese government who regulates that the number of API manufacturers shall not exceed two while the number of prepration makers shall also be limited. Hence the high barrier. The current landscape of Wuhan Humanwell Pharmaceutical Co., Ltd taking the lead might be changed with the entry of China National Medicines Corporation Limited and Jiangsu Nhwa Pharmaceutical Co., Ltd.
According to CRI's market survey, the sales value of remifentanil in sample hospitals exceeded CNY 200 million in 2014 and CAGR during the period of 2005-2014 surpassed 30%. Currently, remifentanil products available in the Chinese market all come from Wuhan Humanwell Pharmaceutical Co., Ltd and China National Pharmaceutical Industry Corporation Ltd, among which the former had the largest market share of over 99% for sales value in 2014.
With ageing population and increasing incidence of various diseases caused by environmental pollution and lifestyle changes, the number of operation in China will keep rising, so does the demand for remifentanil.
Readers can get at least the following information through this report:
The author suggests the following groups of people purchase this report:
8.1Forecast of Market Size